Central Garden & Pet Company Announces Upcoming Investor Conferences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 19 2026
0mins
Should l Buy CENT?
Source: Businesswire
- Investor Conference Participation: Central Garden & Pet Company will participate in upcoming investor conferences, showcasing its leadership in the pet and garden industries, which is expected to attract investor interest and enhance market confidence.
- Financial Performance Overview: The company anticipates net sales of $3.1 billion for fiscal 2025, demonstrating strong performance and growth potential in the market, further solidifying its industry leadership.
- Brand Diversity: Central Garden & Pet Company boasts a diversified portfolio of market-leading brands, including Amdro® and Aqueon®, which enhances brand recognition and competitive positioning among consumers.
- Sustainability Commitment: The company is dedicated to promoting home health through innovative and sustainable solutions, reflecting its commitment to environmental responsibility and enhancing brand image and consumer loyalty.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CENT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CENT
Wall Street analysts forecast CENT stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 36.360
Low
30.00
Averages
43.33
High
50.00
Current: 36.360
Low
30.00
Averages
43.33
High
50.00
About CENT
Central Garden & Pet Company is engaged in the garden and pet industries. The Company offers a portfolio of over 60 brands, including Amdro, Aqueon, Best Bully Sticks, Cadet, C&S, Farnam, Ferry-Morse, Kaytee, Nylabone, Pennington, Sevin, Zoecon, and JustiFLY. Its segments include Pet and Garden. The Pet segment includes dog and cat supplies such as treats and chews, toys, beds and containment, grooming products, waste management and training pads; supplies for aquatics, small animals, reptiles and pet birds including toys, enclosures and habitats, bedding, food and supplements; products for equine and livestock, animal and household health and insect control products; live fish and small animals as well as outdoor cushions. The Garden segment includes lawn and garden consumables such as grass seed; vegetable, flower and herb packet seed; wild bird feed, bird houses and other birding accessories; weed, grass, and other herbicides, insecticide and pesticide products, and live plants.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Partnership Continuation: DoMyOwn extends its collaboration with DIY home improvement expert Richard Karn, who continues as Chief Solutions Officer, enhancing brand visibility and consumer trust in tackling pest issues.
- Innovative Video Content: Karn showcases the simplicity of pest control through new video content, empowering consumers to confidently select appropriate products when facing common pests like ants and mosquitoes, thereby improving purchasing decision efficiency.
- Market Demand Insight: Research by DoMyOwn indicates that 53% of consumers research pest solutions before purchasing, highlighting the importance of providing clear guidance and expertise to meet consumer needs for effective pest control.
- Diverse Products and Services: DoMyOwn offers a wide range of professional-grade products and support to help consumers identify and manage pests, ensuring comfortable, pest-free living environments, further solidifying its leadership in the DIY pest control market.
See More
- Strong Performance of Spectrum Brands: In Q1 of fiscal 2026, Spectrum Brands reported an EPS of $1.40, exceeding expectations by 84%, with revenue reaching $677 million, indicating a recovery in its global pet care segment that is expected to drive future growth.
- Expansion Plans of Central Garden & Pet: Central Garden & Pet had a solid start to fiscal 2026, with management asserting that the current stock price is undervalued, announcing a $100 million expansion of its share buyback program, reflecting confidence in future growth.
- Acquisition Strategy of Prestige Consumer Healthcare: Prestige Consumer Healthcare achieved $283.4 million in revenue in Q3 of fiscal 2026, surpassing expectations despite economic challenges, and successfully acquired eye care supplier Pillar5 Pharma, further strengthening its market position.
- Long-term Wealth Building Potential: All three companies focus on brand acquisition and integration, demonstrating robust wealth growth potential through sustained profitability and cash flow generation in uncertain market conditions.
See More
- Investor Conference Participation: Central Garden & Pet Company will participate in upcoming investor conferences, showcasing its leadership in the pet and garden industries, which is expected to attract investor interest and enhance market confidence.
- Financial Performance Overview: The company anticipates net sales of $3.1 billion for fiscal 2025, demonstrating strong performance and growth potential in the market, further solidifying its industry leadership.
- Brand Diversity: Central Garden & Pet Company boasts a diversified portfolio of market-leading brands, including Amdro® and Aqueon®, which enhances brand recognition and competitive positioning among consumers.
- Sustainability Commitment: The company is dedicated to promoting home health through innovative and sustainable solutions, reflecting its commitment to environmental responsibility and enhancing brand image and consumer loyalty.
See More
- Central Garden & Pet Company: Authorized to purchase up to $100 million of its own stock.
- Stock Buyback Program: Aimed at enhancing shareholder value and reflects confidence in the company's future.
See More
Central Garden & Pet Announcement: Central Garden & Pet has announced an increase in stock repurchase authorization, allowing the company to buy back more of its shares.
Purpose of Repurchase: The stock repurchase is aimed at enhancing shareholder value and reflects the company's confidence in its financial position and future growth prospects.
See More
- New Board Appointment: Central Garden & Pet Company has announced the appointment of Kay M. Schwichtenberg to its Board of Directors, effective March 1, 2026, which is expected to bring extensive leadership experience in consumer products and animal health to the company.
- Extensive Industry Background: Schwichtenberg has over 40 years of experience in the animal health industry, including 29 years at Central, where she most recently served as Executive Vice President of Animal & Public Health, indicating her expertise will likely drive innovation and growth for the company.
- Strategic Value Addition: Bill Brown, Chairman of the Board, noted that Schwichtenberg's operational and executive perspective will add value to the Board, aiding the company in focusing on long-term value creation and market growth.
- Educational and Professional Credentials: Schwichtenberg holds an MBA from the University of Illinois at Chicago and has held leadership positions in various industry associations, showcasing her broad influence and leadership capabilities within the industry.
See More









